We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CWD:NASDAQCaliberCos Inc. Analysis

Data as of 2026-03-28 - not real-time

$1.12

Latest Price

9/10Risk

Risk Level: High

Executive Summary

CaliberCos Inc. (CWD) is in a severe financial tailspin. Revenue has slumped 52.5% YoY to just $20 M, margins are deeply negative (gross margin ~7.5%, operating margin -30.8%, profit margin -108%), and the balance sheet is crippled by $93 M of debt versus only $2.9 M of cash, yielding a staggering debt‑to‑equity ratio of 355. The stock trades at $1.12, well below its 20‑day (1.304) and 50‑day (1.279) SMAs, with a bearish MACD and an RSI of 38, indicating limited upside momentum. Volatility is extreme at 72% over the past 30 days, and beta (1.09) suggests the share moves more than the market.
Technical pressure is compounded by liquidity concerns highlighted in the recent earnings call, where management cited delayed revenue and a need for cost‑saving measures while attempting to diversify into digital assets. The price is hovering near the identified support of $1.06 and faces resistance around $1.55, with volume trending upward, yet the underlying fundamentals and high leverage make any upside highly speculative.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical indicators (price below SMAs, MACD bearish)
  • Severe liquidity strain and high debt load
  • Elevated volatility and low market cap

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from digital‑asset diversification
  • Cost‑saving initiatives may improve cash flow
  • Continued balance‑sheet weakness limits confidence

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Uncertain turnaround prospects amid structural losses
  • High leverage could force restructuring or dilution
  • Sector exposure to real‑estate cycles and emerging digital assets

Key Metrics & Analysis

Financial Health

Revenue Growth-52.50%
Profit Margin-108.46%
P/E Ratio-4.3
ROE-122.86%
ROA-3.93%
Debt/Equity354.94
P/B Ratio5.8
Op. Cash Flow$-12065000
Free Cash Flow$-17311750
Industry P/E16.0

Technical Analysis

TrendNeutral
RSI38.4
Support$1.06
Resistance$1.55
MA 20$1.30
MA 50$1.28
MA 200$2.66
MACDBearish
VolumeIncreasing
Fear & Greed Index65.98

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta1.09
Volatility72.61%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.